DC12185 |
Vabicaserin hydrochloride (SCA 136) |
Vabicaserin hydrochloride is a 5-hydroxytryptamine 2C (5-HT2C) receptor-selective agonist with an EC50 of 8 nM. |
|
DCAPI1452 |
Valsartan |
Valsartan is a nonpeptide angiotensin II AT1-receptor antagonist with an IC50 ranging from 39.5 to 116 μM. This in turn causes blood vessel dilation. |
|
DC11168 |
VCE-004.3 |
VCE-004.3 (VCE004.3) is a novel semi-synthetic cannabidiol derivative behaving as a dual PPARγ/CB2 agonist and CB1 receptor modulator, binds and activates PPARγ (IC50=3.5 uM) and CB2 receptors (pKi=6.69) and antagonizes CB1 receptor (pKi=5.61). |
|
DC7336 |
Vicriviroc maleate(Sch-417690)
Featured
|
Vicriviroc Malate is a potent CKR-5 (CCR5) antagonist with IC50 of 0.91 nM. |
|
DC8814 |
Vipadenant
Featured
|
Vipadenant(BIIB-014) is an adenosine A2a antagonist with Ki of 1.3 nM; less potent for A1(Ki=69 nM). |
|
DC8613 |
Vortioxetine (Lu AA21004)
Featured
|
Vortioxetine (Lu AA21004) is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with IC50 of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively. |
|
DC8288 |
Vortioxetine hydrobromide
Featured
|
Vortioxetine Hcl (Lu AA21004 Hcl) is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with IC50 of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively. |
|
DC12159 |
VU 0238429
Featured
|
VU 0238429 is positive allosteric modulator of muscarinic acetylcholine receptor subtype 5 (mAChR5 or M5), with an EC50 of 1.16 μM. |
|
DC9928 |
VU 0364770
Featured
|
VU 0364770 is a positive allosteric modulator(PAM) of mGlu4 with EC50 of 1.1 μM, exhibits insignificant activity at 68 other receptors, including other mGlu subtypes. |
|
DC12165 |
VU 0365114
Featured
|
VU 0365114 is a mAChR M5 positive allosteric modulator, with an EC50 of 2.7 μM. |
|
DC9497 |
VU0152100
Featured
|
VU0152100 is a potent and selective allosteric potentiator of M4 mAChR with an EC50 of 380 ± 93 nM.
|
|
DC9255 |
VU0357017
Featured
|
VU0357017 hydrochloride is a highly selective M1 agonists that appear to act at an allosteric site to activate the receptor (EC50 = 477 ± 172 nM; pEC50 = 6.37 ± 0.15). |
|
DC11121 |
VU0418506 |
VU0418506 (VU 0418506) is a potent and selective mGlu4 positive allosteric modulator (PAM) with EC50 of 68 nM (hmGlu4). |
|
DC11112 |
VU0453595 |
VU0453595 (VU453595) is a potent, selective M1 positive allosteric modulator (PAM) with EC50 of 3.2 uM (rM1). |
|
DC11123 |
VU0467154 |
VU0467154 (VU 0467154) is a potent, selective M4 mAChR positive allosteric modulator with EC50 of 17.7 nM. |
|
DC11437 |
VU0652957
Featured
|
VU0652957 (VU2957, Valiglurax) is a potent, selective mGlu4 positive allosteric modulator (PAM) with EC50 of 64.6 nM in calcium mobilization human mGlu4/Gqi5 assays; showes excellent pharmacokinetics across species (low CLps, %F > 35%), an acceptable CYP profile (>30 uM vs. 3A4, 2D6 and 2C9, 12.5 uM vs. 2C19 and 1.5 uM vs. 1A2), no CYP induction or timedependent inhibition and excellent metabolite coverage across species; also shows attractive predicted human PK parameters (CLps 5-9 mL/min/kg, Vds 1-2 L/kg and t1/2 2-4 hours). |
|
DC11120 |
VU6004256 |
VU6004256 (VU 6004256) is a highly potent, selective M1 muscarinic acetylcholine receptor (mAChR) positive allosteric modulator with EC50 of 155 nM (mouse M1), significant selectivity over M2-M5 (EC50>30 uM). |
|
DC10717 |
VU6005649
Featured
|
VU6005649 is a dual mGlu7/8 positive allosteric modulator with EC50s of 649 nM and 2.6 μM for mGlu7 and mGlu8, respectively. |
|
DC10136 |
VUF10460
Featured
|
VUF10460 is a non-imidazole histamine H4 receptor agonist; binds to rat H4 receptor with a pKi of 7.46. |
|
DC8851 |
VUF11207
Featured
|
VUF11207 is a highly potent CXCR7 agonist. VUF11207 induces recruitment of β-arrestin2 to the CXCR7 followed by internalization of the receptor. |
|
DC9668 |
WAY181187.HCl(WAY-181,187)
Featured
|
WAY-181187 is a potent and selective 5-HT6 receptor agonist. WAY-181187 possesses high affinity binding (2.2 and 4.8 nM, respectively) at the human 5-HT6 receptor and profile as full receptor agonists (WAY-181187: EC50=6.6 nM, Emax=93%). |
|
DC2050 |
WIN-55212-2 mesylate
Featured
|
WIN 55212-2 (mesylate) is a potent aminoalkylindole cannabinoid (CB) receptor agonist with a Ki of 62.3 and 3.3 nM for human recombinant CB1 and CB2 receptors, respectively. |
|
DC7341 |
WZ 811
Featured
|
WZ811 is a novel small molecular and potency CXCR4 antagonist with EC50 of 0.3 nM. |
|
DC9498 |
Xanomeline (oxalate) |
Xanomeline(LY246708) is a selective M1 muscarinic receptor agonist.
|
|
DC11248 |
XL-001 |
XL-001 (XL001) is a novel specific CB2 inverse agonist with Ki of 0.5 nM. |
|
DC9007 |
Xylazine hydrochloride |
Xylazine Hydrochloride is α2 class of adrenergic receptor agonist. |
|
DC9932 |
YL-0919
Featured
|
YL-0919 is a novel synthetic compound with combined high affinity and selectivity for serotonin transporter and 5-HT1A receptors. |
|
DCAPI1015 |
Zafirlukast(Accolate) |
Zafirlukast(Accolate) |
|
DC9435 |
Zibotentan(ZD4054)
Featured
|
Zibotentan (ZD4054) is an orally administered, potent and specific ETA-receptor (endothelin A receptor) antagonist (IC50 = 21 nM). |
|
DCAPI1039 |
Ziprasidone HCl |
Ziprasidone HCl |
|